H 77

angiotensinogen (6-13)-octapeptide in which the peptide bond -CO-NH- at the Leu(9)-Leu(11) linkage is replaced by a -CH2-NH- bond; RN given refers to (D)-isomer

Also Known As:

H 77, (L)-isomer; H-77; L-Tyrosine, N-(N-(N-(2-((N-(N-(1-D-histidyl-L-prolyl)-L-phenylalanyl)-L-histidyl)amino)-4-methylpentyl)-L-leucyl)-L-valyl)-, (S)-

Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - H 77: 14

Experts

1.	Cadoo, Karen A: 1 article (01/2022)
2.	Carlo, Maria I: 1 article (01/2022)
3.	Catchings, Amanda: 1 article (01/2022)
4.	Ceyhan-Birsoy, Ozge: 1 article (01/2022)
5.	Kane, Sarah: 1 article (01/2022)
6.	Kemel, Yelena: 1 article (01/2022)
7.	Latham, Alicia: 1 article (01/2022)
8.	Liu, Ying L: 1 article (01/2022)
9.	Maio, Anna: 1 article (01/2022)
10.	Mandelker, Diana: 1 article (01/2022)

Related Diseases

1.	Hodgkin Disease (Hodgkin's Disease) 11/01/1985 - "From April 1972 to May 1980, 72 children and adolescents (aged 5 to 19 years old, median 16) with Hodgkin's disease, clinical stages IA-IIB (IA, 18; II2A, two areas involved on the same side of the diaphragm, 23; II3+A, three areas or more, 16; IIB, 15) were prospectively treated in two successive clinical trials (H 72 and H 77). "
2.	Venous Thrombosis (Deep-Vein Thrombosis) 07/01/2005 - "The following differences were found between arterial and venous events: arterial thrombosis occurred early after IVIg administration (49% within 4 h, 77% within 24 h) and was associated with advanced age and atherosclerotic vascular disease; venous thrombosis occurred later (54% more than 24 h after IVIg administration) and was associated with factors contributing to venous stasis (obesity and immobility). "
3.	Arthralgia (Joint Pain) 10/01/2003 - "Significantly more women with ruptured implants than those with intact implants had debilitating chronic fatigue (75% vs 51%), postexertional malaise > 24 h (77% vs 51%), impaired short term memory (58% vs 38%), and multi-joint pain (77% vs 60%). "
4.	Endometrial Neoplasms (Endometrial Cancer) 01/01/2022 - "Of 261 pooled tumors, colorectal cancer (CRC) and endometrial cancer (EC) comprised 55% and 43% of cancers in MSH6 and PMS2, respectively; 192 tumors underwent molecular assessments and 122 (64%) were MMR-D/MSI-H (77 in MSH6, 45 in PMS2). "
5.	Colorectal Neoplasms (Colorectal Cancer) 01/01/2022 - "Of 261 pooled tumors, colorectal cancer (CRC) and endometrial cancer (EC) comprised 55% and 43% of cancers in MSH6 and PMS2, respectively; 192 tumors underwent molecular assessments and 122 (64%) were MMR-D/MSI-H (77 in MSH6, 45 in PMS2). "

Related Drugs and Biologics

1.	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)
2.	Sumatriptan (Imigran)
3.	Ondansetron (Zofran)
4.	Intravenous Immunoglobulins (IVIG)
5.	Glucose (Dextrose)
6.	H 74

Related Therapies and Procedures

1.	Critical Care (Surgical Intensive Care)